Sign Up to like & get
recommendations!
1
Published in 2020 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-1111-8775
Abstract: For patients with locally advanced or metastatic breast cancer, new and effective therapies such as CDK4/6 inhibitors, PARP inhibitors and a PD-L1 inhibitor have been introduced in recent years. This review presents an update on…
read more here.
Keywords:
cancer new;
breast;
breast cancer;
cancer 2020 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-1464-0953
Abstract: This review summarises not only the latest evidence on prevention, but also the current research on the treatment of early-stage breast cancer patients. Recent years have seen a growing body of evidence on the risk…
read more here.
Keywords:
breast;
treatment;
breast cancer;
prevention ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-1724-9639
Abstract: This past year has seen new and effective options for further improving treatment outcome in many patients with early-stage breast cancer. Patients with hormone receptor-positive disease benefited significantly from the addition of the CDK4/6 inhibitor…
read more here.
Keywords:
breast;
update breast;
inhibitor;
cancer 2021 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-1811-6148
Abstract: Abstract Large-scale study programs on CDK4/6 inhibitors, targeted therapies, and antibody–drug conjugates launched in recent years have yielded results from current studies which are now being published in journals and presented at international conferences. In…
read more here.
Keywords:
cancer 2022;
breast;
update breast;
breast cancer ... See more keywords